Table 3 The relationship between the serum markers and the location, size, and TNM stage of pancreatic cancer
From: Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer
Group | Number | CEA | CA19-9 | CA242 | |||
|---|---|---|---|---|---|---|---|
value (ng/ml) | P-value | value (ng/ml) | P-value | value (ng/ml) | P-value | ||
Tumor location head | 48 | 20.6 ± 42.6 | 756.6 ± 1,228.2 | 58.3 ± 55.3 | |||
Body/tail | 146 | 28.0 ± 33.1 | 2,902.5 ± 3,308.3 | 76.1 ± 72.1 | |||
Whole | 59 | 74.9 ± 232.1 | P >0.5 | 1,517.3 ± 2,928.6 | P <0.5 | 72.6 ± 60.3 | P >0.5 |
Tumor size | |||||||
≤ 5 cm | 166 | 23.7 ± 39.1 | 1,113.4 ± 2,660.4 | 45.2 ± 48.1 | |||
> 5 cm | 69 | 23.9 ± 36.3 | P >0.5 | 1,258.9 ± 5,002.3 | P >0.5 | 59.1 ± 60.3 | P >0.5 |
TNM stage | |||||||
I | 22 | 14.1 ± 16.6 | 1,126.6 ± 1,425.9 | 57.6 ± 54.4 | |||
II | 140 | 12.7 ± 28.3 | 845.0 ± 2,000.7 | 53.9 ± 52.1 | |||
III | 73 | 90.3 ± 212.8 | P <0.5 | 2,976.6 ± 3,513.2 | P <0.5 | 97.6 ± 67.1 | P <0.5 |